Permanent link to this press release:
Delete press release Edit press rele
Permanent link to this press release:
Delete press release Edit press rele
Do you value your experience at TMC? Consider becoming a Supporting Member of Tesla Motors Club. As a thank you for your contribution, you'll get nearly no ads in the Community and Groups sections. Additional perks are available depending on the level of contribution. Please visit the Account
Ready for some quotes? Enter your postcode now
Ronald attended the Charge Together electric vehicle event In Adelaide. Here’s what happened…
I attended an electric car event here in Adelaide on Sunday. I thought it was a reasonable thing to do as I’d recently w
Nearly 100 plug-in cars and a stack of second-life EV batteries successfully responded to dozens of demand response calls.
BMW and PG&E Prove Electric Vehicles Can Be a Valuable Grid Resource
The concept of using electric vehicles as a grid resource is no longer just theory. A
The sun is slowly starting to rise on the solar industry and business is booming.
This growth in the solar energy sector is anchored on the Kenya National Electrification Strategy (KNES) which aims to achieve electricity access to all in the shortest time possible.
As a re
BSLBATT, a global manufacturer and supplier of lithium-ion energy storage solutions, is debuting a new residential energy storage innovation that they say is more in line with what customers are demanding: the 20 kWh Off Grid Home Battery.
Based on customer feedback and BSL’s fin
Massmart-owned retailer Makro says it will start offering power walls and full solar installations as it sees increasing demand for load shedding supplies.
Gary Lindhorst, Makro’s DIY merchandise manager, said the retailer has reported ‘exceptionally strong sales growths’ f
The best of EcoWatch right in your inbox. Sign up for our email newsletter!
Here’s what we’ll cover in this guide:
Why You Can Trust EcoWatch
We work with a panel of solar experts to create unbiased reviews that empower you to make the
Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis
Dupixent significantly reduced itch at 12 weeks, and at 24 weeks nearly three times as many Dupixent patients experienced clinically meaningful reductions in